Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

Voriconazole can cause serious side effects, especially in long-term use.

Jasmonic acid and its derivatives play important roles in plant health and have potential uses in medicine and agriculture.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.